Yeast as a biological platform for vitamin D production: A promising alternative to help reduce vitamin D deficiency in humans
Abstract
Vitamin D is an important human hormone, known primarily to be involved in the intestinal absorption of calcium and phosphate, but it is also involved in various nonskeletal processes (molecular, cellular, immune, and neuronal). One of the main health problems nowadays is the vitamin D deficiency of the human population due to lack of sun exposure, with estimates of one billion people worldwide with vitamin D deficiency, and the consequent need for clinical intervention (i.e., prescription of pharmacological vitamin D supplements). An alternative to reduce vitamin D deficiency is to produce good dietary sources of it, a scenario in which the yeast Saccharomyces cerevisiae seems to be a promising alternative. This review focuses on the potential use of yeast as a biological platform to produce vitamin D, summarizing both the biological aspects of vitamin D (synthesis, ecology and evolution, metabolism, and bioequivalence) and the work done to produce it in yeast (both for vitamin D2 and for vitamin D3), highlighting existing challenges and potential solutions.Keywords
This publication has 117 references indexed in Scilit:
- Genetic and Phenotypic Characteristics of Baker's Yeast: Relevance to BakingAnnual Review of Food Science and Technology, 2013
- Vitamin D4 in MushroomsPLOS ONE, 2012
- Comparison of vitamin D2 and vitamin D3 supplementation in raising serum 25-hydroxyvitamin D status: a systematic review and meta-analysisThe American Journal of Clinical Nutrition, 2012
- Bioavailability and Efficacy of Vitamin D2 from UV-Irradiated Yeast in Growing, Vitamin D-Deficient RatsJournal of Agricultural and Food Chemistry, 2011
- Vitamin D Effects on Lung Immunity and Respiratory Diseases2011
- Vitamin D2 Is as Effective as Vitamin D3 in Maintaining Circulating Concentrations of 25-Hydroxyvitamin DThe Journal of Clinical Endocrinology & Metabolism, 2008
- Vitamin D and autoimmunity: new aetiological and therapeutic considerationsAnnals of the Rheumatic Diseases, 2007
- Vitamin D DeficiencyNew England Journal of Medicine, 2007
- Combined overexpression of genes of the ergosterol biosynthetic pathway leads to accumulation of sterols inFEMS Yeast Research, 2003
- 1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin systemJournal of Clinical Investigation, 2002